These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28370399)

  • 21. A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.
    Reading NS; Ruiz-Bonilla JA; Christensen RD; Cáceres-Perkins W; Prchal JT
    Am J Hematol; 2017 May; 92(5):474-477. PubMed ID: 28195434
    [No Abstract]   [Full Text] [Related]  

  • 22. Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.
    Bontant T; Le Garrec S; Avran D; Dauger S
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25115783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pegloticase-Associated Hemolysis.
    Minshar MA; Osman-Malik Y; Bhat ZY
    Am J Ther; 2019; 26(5):e622-e624. PubMed ID: 30211701
    [No Abstract]   [Full Text] [Related]  

  • 24. Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient.
    Bhat P; Sisler I; Collier AB
    Pediatr Blood Cancer; 2008 Oct; 51(4):568. PubMed ID: 18561168
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe acute haemolytic anaemia associated with severe methaemoglobinaemia in a G6PD-deficient man.
    Rehman A; Shehadeh M; Khirfan D; Jones A
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29592989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin's Lymphoma.
    Alessa MA; Craig AK; Cunningham JM
    Am J Case Rep; 2015 Sep; 16():590-3. PubMed ID: 26334783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rasburicase-induced methemoglobinemia in a patient with leukemia recurrence].
    Pavo García MR; Núñez-Ramos R; Peralta Salas JE; Vivanco Martínez JL
    An Pediatr (Barc); 2014 Dec; 81(6):e38-9. PubMed ID: 24588957
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyanosis in a male Nigerian infant with acute kidney injury: answers.
    Pansy J; Mache CJ; Zobel G; Grangl G; Ring E; Hoffmann KM
    Pediatr Nephrol; 2014 Jun; 29(6):1011-3. PubMed ID: 23989394
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe methemoglobinemia and syncope in a patient with glucose-6-phosphate dehydrogenase deficiency.
    Swissa M; Shaked Y; Garty M
    Isr Med Assoc J; 2007 Sep; 9(9):684-5. PubMed ID: 17939637
    [No Abstract]   [Full Text] [Related]  

  • 30. Low Hemoglobin Saturation in the Setting of Hyperuricemia.
    Jung S; Sayad K; Staitieh BS
    Ann Am Thorac Soc; 2019 Nov; 16(11):1447-1450. PubMed ID: 31674816
    [No Abstract]   [Full Text] [Related]  

  • 31. Aniline-induced methaemoglobinaemia in a glucose-6-phosphate dehydrogenase enzyme deficient patient.
    Mullick P; Kumar A; Dayal M; Babbar S; Kumar A
    Anaesth Intensive Care; 2007 Apr; 35(2):286-8. PubMed ID: 17444323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalase deficiency may complicate urate oxidase (rasburicase) therapy.
    Góth L; Bigler NW
    Free Radic Res; 2007 Sep; 41(9):953-5. PubMed ID: 17729111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemolytic anemia due to G6PD deficiency and urate oxidase in a kidney-transplant patient.
    Ducros J; Saingra S; Rampal M; Coulange C; Barbe MC; Verzetti G
    Clin Nephrol; 1991 Feb; 35(2):89-90. PubMed ID: 2019023
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.
    Relling MV; McDonagh EM; Chang T; Caudle KE; McLeod HL; Haidar CE; Klein T; Luzzatto L;
    Clin Pharmacol Ther; 2014 Aug; 96(2):169-74. PubMed ID: 24787449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rasburicase-induced Methemoglobinemia: A Case Report and Literature Review.
    Pirrone I; Farruggia P; Cacciatore F; Giambona A; Guarina A; Marcello AP; Mosa C; Scalzo S; D'Angelo P
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e886-e890. PubMed ID: 33122582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of pre-emptive rapid testing for glucose-6-phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study.
    Ganapathi M; Campbell P; Ofori K; Aggarwal V; Francis RO; Kratz A
    Br J Clin Pharmacol; 2022 Sep; 88(9):4163-4170. PubMed ID: 35419830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue.
    Brewer GJ
    Am J Hematol; 2007 Jan; 82(1):87-8. PubMed ID: 16917918
    [No Abstract]   [Full Text] [Related]  

  • 38. Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine.
    Foltz LM; Dalal BI; Wadsworth LD; Broady R; Chi K; Eisenhauer E; Kobayashi K; Kollmannsburger C
    Am J Hematol; 2006 Mar; 81(3):210-1. PubMed ID: 16493607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rasburicase-induced methaemoglobinaemia and catastrophic oxidative haemolysis in undiagnosed G6PD deficiency.
    Wilson J
    Br J Haematol; 2023 Jan; 200(1):7. PubMed ID: 36120836
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapidly rising methemoglobinemia in a patient with severe COVID-19 treated successfully with red cell exchange transfusion.
    Choo SY
    Ther Apher Dial; 2021 Oct; 25(5):710-711. PubMed ID: 33040413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.